% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • sarathsathkumara sarathsathkumara May 6, 2013 3:19 PM Flag

    What If NeuVax is Given "Breakthough Designation" by the FDA!!!

    This is a possibilty GALE investors cannot overlook.

    On March 15th, Novartis (NVS), Europe's largest pharma company received such status from the FDA for its LDK378 compound that treats lung cancer, just after the Phase1 trial with just 88 patients. Nearly 4/5 of the volunteers participated in the trial shrank their tumors.

    NVS is seekking approval for the drug within a year while conducting P2/3 trials.

    If such a thing happens, GALE will be off to the moon with just $200mm MC!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.4446-0.0254(-5.40%)Jul 29 4:00 PMEDT